Citation: Kj. Wirth et al., DIFFERENCES IN ACETYLCHOLINE AND BRADYKININ-INDUCED VASORELAXATION OFTHE MESENTERIC VASCULAR BED IN SPONTANEOUSLY HYPERTENSIVE RATS OF DIFFERENT AGES, Naunyn-Schmiedeberg's archives of pharmacology, 354(1), 1996, pp. 38-43
Authors:
LINZ W
WIEMER G
SCHAPER J
ZIMMERMANN R
NAGASAWA K
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, LEFT-VENTRICULAR HYPERTROPHY AND FIBROSIS, Molecular and cellular biochemistry, 147(1-2), 1995, pp. 89-97
Citation: P. Wohlfart et al., POSSIBLE PHYSIOLOGICAL-ROLE OF ANGIOTENSI N II-(SUBTYPE AT(2))-RECEPTORS IN ISCHEMIC RAT HEARTS AND BOVINE AORTIC ENDOTHELIAL-CELLS, Nieren- und Hochdruckkrankheiten, 24(6), 1995, pp. 311-314
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CONTRIBUTION OF KININS TO THE CARDIOVASCULAR ACTIONS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, Pharmacological reviews, 47(1), 1995, pp. 25-49
Authors:
GOHLKE P
LINZ W
SCHOLKENS BA
WIEMER G
MARTORANA P
VANEVEN P
UNGER T
Citation: P. Gohlke et al., EFFECT OF CHRONIC HIGH-DOSE AND LOW-DOSE ACE-INHIBITOR TREATMENT ON CARDIAC AND VASCULAR HYPERTROPHY AND VASCULAR FUNCTION IN SPONTANEOUSLYHYPERTENSIVE RATS, Experimental nephrology, 2(2), 1994, pp. 93-93
Citation: Kj. Wirth et al., THE BRADYKININ-B-2 RECEPTOR ANTAGONIST WIN-64338 INHIBITS THE EFFECT OF DES-ARG(9)-BRADYKININ IN ENDOTHELIAL-CELLS, European journal of pharmacology. Molecular pharmacology section, 288(1), 1994, pp. 1-2
Authors:
LINZ W
WIEMER G
GOHLKE P
UNGER T
SCHOLKENS BA
Citation: W. Linz et al., CARDIOPROTECTIVE EFFECTS BY RAMIPRIL AFTER ISCHEMIA AND REPERFUSION IN EXPERIMENTAL STUDIES, Zeitschrift fur Kardiologie, 83, 1994, pp. 53-56
Authors:
WIEMER G
FINK E
KORTH P
WOHLFART P
SCHOLKENS BA
LINZ W
Citation: G. Wiemer et al., BLOCKADE OF ANG-II (SUBTYPE AT(1)) RECEPTORS INDUCES KININ AND PROSTACYCLIN RELEASE FROM ISOLATED-PERFUSED RAT HEARTS, Hypertension, 24(3), 1994, pp. 396-396
Citation: W. Linz et al., CARDIOPROTECTIVE ACTIONS OF BRADYKININ IN MYOCARDIAL-ISCHEMIA AND LEFT-VENTRICULAR HYPERTROPHY, Brazilian journal of medical and biological research, 27(8), 1994, pp. 1949-1954
Authors:
HROPOT M
GROTSCH H
KLAUS E
LANGER KH
LINZ W
WIEMER G
SCHOLKENS BA
Citation: M. Hropot et al., RAMIPRIL PREVENTS THE DETRIMENTAL SEQUELS OF CHRONIC NO SYNTHASE INHIBITION IN RATS - HYPERTENSION, CARDIAC-HYPERTROPHY AND RENAL-INSUFFICIENCY, Naunyn-Schmiedeberg's archives of pharmacology, 350(6), 1994, pp. 646-652
Authors:
WIEMER G
FINK E
LINZ W
HROPOT M
SCHOLKENS BA
WOHLFART P
Citation: G. Wiemer et al., FUROSEMIDE ENHANCES THE RELEASE OF ENDOTHELIAL KININS, NITRIC-OXIDE AND PROSTACYCLIN, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1611-1615
Citation: G. Wiemer et al., ENHANCEMENT OF CYTOSOLIC CALCIUM, PROSTACYCLIN AND NITRIC-OXIDE BY BRADYKININ AND THE ACE-INHIBITOR RAMIPRILAT IN PORCINE BRAIN CAPILLARY ENDOTHELIAL-CELLS, Brain research, 638(1-2), 1994, pp. 261-266
Authors:
WIEMER G
SCHOLKENS A
WAGNER A
HEITSCH H
LINZ W
Citation: G. Wiemer et al., THE POSSIBLE ROLE OF ANGIOTENSIN-II SUBTYPE AT(2) RECEPTORS IN ENDOTHELIAL-CELLS AND ISOLATED ISCHEMIC RAT HEARTS, Journal of hypertension, 11, 1993, pp. 190000234-190000235
Citation: W. Linz et al., CONTRIBUTION OF BRADYKININ TO THE CARDIOVASCULAR EFFECTS OF RAMIPRIL, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000001-190000008